Suppr超能文献

慢性血液透析患者静脉注射美洛西林的药代动力学

Kinetics of intravenous mezlocillin in chronic hemodialysis patients.

作者信息

Francke E, Mehta S, Neu H C, Appel G B

出版信息

Clin Pharmacol Ther. 1979 Aug;26(2):228-31. doi: 10.1002/cpt1979262228.

Abstract

The kinetics of intravenous mezlocillin was studied in 8 patients with creatinine clearances under 7 ml/min who were undergoing chronic hemodialysis. Kinetic parameters were determined using a 2-compartment linear model. The mezlocillin serum half-life (t 1/2) in these patients ranged from 2.9 to 7.8 hr (mean, 5.4). The t 1/2 decreased to 1.57 +/- 0.09 hr during dialysis. Approximately 18% of the dose was recovered in the dialysate in 4 hr of dialysis. There was a 30% reduction per hour in serum concentration. The kinetics of mezlocillin, due to removal by nonrenal mechanisms, more closely resemble the kinetics of penicillin G and ampicillin than of carbenicillin and ticarcillin. A dosage schedule for use of intravenous mezlocillin in patients undergoing hemodialysis is presented.

摘要

对8例肌酐清除率低于7ml/分钟且正在接受慢性血液透析的患者进行了静脉注射美洛西林的动力学研究。使用二室线性模型确定动力学参数。这些患者中美洛西林的血清半衰期(t1/2)为2.9至7.8小时(平均5.4小时)。透析期间t1/2降至1.57±0.09小时。在4小时的透析过程中,约18%的剂量在透析液中回收。血清浓度每小时降低30%。由于非肾脏机制的清除作用,美洛西林的动力学更类似于青霉素G和氨苄西林,而不是羧苄西林和替卡西林。本文给出了血液透析患者静脉注射美洛西林的用药方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验